{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T01:14:35Z","timestamp":1789002875225,"version":"build-2803163510"},"reference-count":107,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1053\/j.ajkd.2011.12.032","type":"journal-article","created":{"date-parts":[[2012,4,4]],"date-time":"2012-04-04T07:30:28Z","timestamp":1333524628000},"page":"874-885","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Hepatorenal Syndrome: A Severe, but Treatable, Cause of Kidney Failure in Cirrhosis"],"prefix":"10.1053","volume":"59","author":[{"given":"Cl\u00e1udia","family":"Fagundes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Gin\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6953","key":"10.1053\/j.ajkd.2011.12.032_bib1","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0140-6736(56)90149-0","article-title":"Electrolyte and circulatory changes in terminal liver failure","volume":"271","author":"Hecker","year":"1956","journal-title":"Lancet"},{"issue":"6","key":"10.1053\/j.ajkd.2011.12.032_bib2","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/0002-9343(67)90247-1","article-title":"Renal failure in patients with cirrhosis of the liver","volume":"43","author":"Schroeder","year":"1967","journal-title":"Am J Med"},{"issue":"2","key":"10.1053\/j.ajkd.2011.12.032_bib3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0002-9343(70)80073-0","article-title":"Renal failure in the patient with cirrhosis","volume":"49","author":"Epstein","year":"1970","journal-title":"Am J Med"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.032_bib4","first-page":"164","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis","volume":"23","author":"Arroyo","year":"1996","journal-title":"Hepatology"},{"issue":"9","key":"10.1053\/j.ajkd.2011.12.032_bib5","first-page":"1310","article-title":"Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis","volume":"56","author":"Salerno","year":"2007","journal-title":"Gut"},{"issue":"2","key":"10.1053\/j.ajkd.2011.12.032_bib6","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury","volume":"11","author":"Mehta","year":"2007","journal-title":"Crit Care"},{"issue":"5","key":"10.1053\/j.ajkd.2011.12.032_bib7","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/gut.2010.236133","article-title":"Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis","volume":"60","author":"Wong","year":"2011","journal-title":"Gut"},{"issue":"suppl 4","key":"10.1053\/j.ajkd.2011.12.032_bib8","first-page":"311A","article-title":"Urinary neutrophil gelatinase associated lipocalin (UNGAL) distinguishes type of kidney failure and predicts mortality in patients with cirrhosis [abstract]","volume":"50","author":"Verna","year":"2009","journal-title":"Hepatology"},{"issue":"4","key":"10.1053\/j.ajkd.2011.12.032_bib9","first-page":"1234A","article-title":"Evaluation of four different urinary biomarkers in the assessment of renal failure in cirrhosis","volume":"54","author":"Fagundes","year":"2011","journal-title":"Hepatology"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.032_bib10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0016-5085(93)90031-7","article-title":"Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites","volume":"105","author":"Gin\u00e8s","year":"1993","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1053\/j.ajkd.2011.12.032_bib11","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.cgh.2006.08.007","article-title":"Natural history of patients hospitalized for management of cirrhotic ascites","volume":"4","author":"Planas","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.032_bib12","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0016-5085(70)80100-7","article-title":"Functional renal failure in cirrhosis","volume":"58","author":"Lieberman","year":"1970","journal-title":"Gastroenterology"},{"issue":"22","key":"10.1053\/j.ajkd.2011.12.032_bib13","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1056\/NEJM197311292892201","article-title":"Recovery from \u201chepatorenal syndrome\u201d after orthotopic liver transplantation","volume":"289","author":"Iwatsuki","year":"1973","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.032_bib14","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0016-5085(87)90327-1","article-title":"Effects of renal impairment on liver transplantation","volume":"93","author":"Rimola","year":"1987","journal-title":"Gastroenterology"},{"issue":"13","key":"10.1053\/j.ajkd.2011.12.032_bib15","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMra0809139","article-title":"Renal failure in cirrhosis","volume":"361","author":"Gin\u00e8s","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2011.12.032_bib16","series-title":"Diseases of the Kidney and Urinary Tract","first-page":"2179","article-title":"Liver disease and the kidney","author":"Gin\u00e8s","year":"2007"},{"issue":"5","key":"10.1053\/j.ajkd.2011.12.032_bib17","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilatation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis","volume":"8","author":"Schrier","year":"1988","journal-title":"Hepatology"},{"issue":"2","key":"10.1053\/j.ajkd.2011.12.032_bib18","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/hep.20766","article-title":"Circulatory function and hepatorenal syndrome in cirrhosis","volume":"42","author":"Ruiz-del-Arbol","year":"2005","journal-title":"Hepatology"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.032_bib19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/gut.2009.180570","article-title":"Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites","volume":"59","author":"Krag","year":"2010","journal-title":"Gut"},{"issue":"5","key":"10.1053\/j.ajkd.2011.12.032_bib20","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1053\/jhep.2003.50447","article-title":"Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis","volume":"38","author":"Ru\u00edz-del-Arbol","year":"2003","journal-title":"Hepatology"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.032_bib21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0168-8278(03)00160-0","article-title":"Plasma volume expansion by albumin in cirrhosis","volume":"39","author":"Brinch","year":"2003","journal-title":"J Hepatol"},{"key":"10.1053\/j.ajkd.2011.12.032_bib22","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0002-9343(86)90912-5","article-title":"Renal function abnormalities, prostaglandins, and effects of non steroidal anti-inflammatory drugs in cirrhosis with ascites","volume":"25","author":"Arroyo","year":"1986","journal-title":"Am J Med"},{"issue":"8","key":"10.1053\/j.ajkd.2011.12.032_bib23","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJM199808203390807","article-title":"Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis","volume":"339","author":"Martin","year":"1998","journal-title":"N Engl J Med"},{"issue":"2 suppl 1","key":"10.1053\/j.ajkd.2011.12.032_bib24","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1002\/hep.20993","article-title":"The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule","volume":"43","author":"Iwakiri","year":"2006","journal-title":"Hepatology"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.032_bib25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1053\/gast.2002.30305","article-title":"Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat","volume":"122","author":"Ros","year":"2002","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1053\/j.ajkd.2011.12.032_bib26","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1172\/JCI7458","article-title":"Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility","volume":"104","author":"Wiest","year":"1999","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1053\/j.ajkd.2011.12.032_bib27","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/hep.20632","article-title":"Bacterial translocation (BT) in cirrhosis","volume":"41","author":"Wiest","year":"2005","journal-title":"Hepatology"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.032_bib28","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1053\/jhep.2003.50038","article-title":"Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement","volume":"37","author":"Albillos","year":"2003","journal-title":"Hepatology"},{"issue":"3","key":"10.1053\/j.ajkd.2011.12.032_bib29","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/hep.22083","article-title":"Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis","volume":"47","author":"Franc\u00e9s","year":"2008","journal-title":"Hepatology"},{"issue":"11","key":"10.1053\/j.ajkd.2011.12.032_bib30","doi-asserted-by":"crossref","first-page":"985","DOI":"10.7326\/0003-4819-127-11-199712010-00007","article-title":"Effect of fluoroquinolone on the enhanced nitric oxide-induced peripheral vasodilation seen in cirrhosis","volume":"127","author":"Chin-Dusting","year":"1997","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1053\/j.ajkd.2011.12.032_bib31","doi-asserted-by":"crossref","first-page":"186","DOI":"10.7326\/0003-4819-139-3-200308050-00008","article-title":"The effect of selective intestinal decontamination on the hyperdynamic circulatory state in cirrhosis: a randomized trial","volume":"139","author":"Rasaratnam","year":"2003","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1053\/j.ajkd.2011.12.032_bib32","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1053\/j.gastro.2007.06.065","article-title":"Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis","volume":"133","author":"Fern\u00e1ndez","year":"2007","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1053\/j.ajkd.2011.12.032_bib33","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1478-3231.2011.02579.x","article-title":"Endothelial dysfuncytion in the regulation of cirrhosis and portal hypertension [published online ahead of print]","volume":"32","author":"Iwakiri","year":"2012","journal-title":"Liver Int"},{"key":"10.1053\/j.ajkd.2011.12.032_bib34","series-title":"Chronic Liver Failure","article-title":"Angiogenesis and vascular growth in liver diseases","author":"Morales-Ruiz","year":"2011"},{"key":"10.1053\/j.ajkd.2011.12.032_bib35","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/0016-5085(89)90396-X","article-title":"Reduced central blood volume in cirrhosis","volume":"97","author":"Henriksen","year":"1989","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1053\/j.ajkd.2011.12.032_bib36","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0168-8278(01)00175-1","article-title":"Blood volume distribution in patients with cirrhosis: aspects of the dual head gamma-camera technique","volume":"35","author":"Kiska-Kanowitz","year":"2001","journal-title":"J Hepatol"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.032_bib37","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1055\/s-2008-1040321","article-title":"Cirrhotic cardiomyopathy","volume":"28","author":"Alqahtani","year":"2008","journal-title":"Semin Liver Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.032_bib38","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jhep.2010.02.023","article-title":"Cirrhotic cardiomyopathy","volume":"53","author":"M\u00f8ller","year":"2010","journal-title":"J Hepatol"},{"issue":"suppl","key":"10.1053\/j.ajkd.2011.12.032_bib39","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/S0168-8278(11)60141-4","article-title":"Impact of relative adrenal insufficiency on circulatory function and mortality in advanced cirrhosis [abstract]","volume":"54","author":"Acevedo","year":"2011","journal-title":"J Hepatol"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.032_bib40","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/hep.21940","article-title":"Lack of renal improvement with nonselective endothelin antagonism with tezosentan in type 2 hepatorenal syndrome","volume":"47","author":"Wong","year":"2008","journal-title":"Hepatology"},{"issue":"5","key":"10.1053\/j.ajkd.2011.12.032_bib41","first-page":"788","article-title":"Brachial and femoral artery blood flow in cirrhosis: relationship to kidney dysfunction","volume":"17","author":"Maroto","year":"1993","journal-title":"Hepatology"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.032_bib42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/hep.510280107","article-title":"Increased cerebral vascular resistance in cirrhotic patients with ascites","volume":"28","author":"Guevara","year":"1998","journal-title":"Hepatology"},{"key":"10.1053\/j.ajkd.2011.12.032_bib43","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jhep.2004.05.009","article-title":"Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"41","author":"Fern\u00e1ndez","year":"2004","journal-title":"J Hepatol"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.032_bib44","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/hep.510270107","article-title":"Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion","volume":"27","author":"Guevara","year":"1998","journal-title":"Hepatology"},{"key":"10.1053\/j.ajkd.2011.12.032_bib45","series-title":"Chronic Liver Failure","first-page":"239","article-title":"Regulation of the extracellular fluid volume and renal function","author":"Henriksen","year":"2011"},{"issue":"6","key":"10.1053\/j.ajkd.2011.12.032_bib46","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/hep.20687","article-title":"MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation","volume":"41","author":"Alessandria","year":"2005","journal-title":"Hepatology"},{"issue":"2","key":"10.1053\/j.ajkd.2011.12.032_bib47","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1053\/j.gastro.2010.07.043","article-title":"Prognostic importance of the cause of renal failure in patients with cirrhosis","volume":"140","author":"Mart\u00edn-Llah\u00ed","year":"2011","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1053\/j.ajkd.2011.12.032_bib48","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2007.04.010","article-title":"Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded pilot study","volume":"47","author":"Alessandria","year":"2007","journal-title":"J Hepatol"},{"issue":"2","key":"10.1053\/j.ajkd.2011.12.032_bib49","first-page":"152","article-title":"Acute-on-chronic liver failure: from concept to a new syndrome","volume":"17","author":"Jalan","year":"2011","journal-title":"Curr Opin Crit Care"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2011.12.032_bib50","doi-asserted-by":"crossref","first-page":"S381","DOI":"10.1016\/S0168-8278(11)60954-9","article-title":"MELD\u2014sodium predicts survival and development of type 1 hepatorenal syndrome in patients with type 2 hepatorenal syndrome [abstract]","volume":"54","author":"Pereira","year":"2011","journal-title":"J Hepatol"},{"issue":"5","key":"10.1053\/j.ajkd.2011.12.032_bib51","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jhep.2007.02.001","article-title":"Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome","volume":"46","author":"Arroyo","year":"2007","journal-title":"J Hepatol"},{"issue":"6","key":"10.1053\/j.ajkd.2011.12.032_bib52","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/hep.1840200619","article-title":"Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis","volume":"20","author":"Follo","year":"1994","journal-title":"Hepatology"},{"issue":"5","key":"10.1053\/j.ajkd.2011.12.032_bib53","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/hep.510270507","article-title":"Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality","volume":"27","author":"Navasa","year":"1998","journal-title":"Hepatology"},{"issue":"3","key":"10.1053\/j.ajkd.2011.12.032_bib54","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1478-3231.2008.01877.x","article-title":"Serum creatinine and bilirubin predict renal failure and mortality in patients with spontaneous bacterial peritonitis: a retrospective study","volume":"29","author":"Terg","year":"2009","journal-title":"Liver Int"},{"issue":"6","key":"10.1053\/j.ajkd.2011.12.032_bib55","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"341","author":"Sort","year":"1999","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1053\/j.ajkd.2011.12.032_bib56","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1053\/j.gastro.2005.09.024","article-title":"Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score","volume":"129","author":"Terra","year":"2005","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1053\/j.ajkd.2011.12.032_bib57","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1002\/hep.21920","article-title":"Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure","volume":"46","author":"Thabut","year":"2007","journal-title":"Hepatology"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2011.12.032_bib58","doi-asserted-by":"crossref","first-page":"S380","DOI":"10.1016\/S0168-8278(11)60952-5","article-title":"Hepatorenal syndrome associated with bacterial infections in cirrhosis","volume":"54","author":"Fagundes","year":"2011","journal-title":"J Hepatol"},{"issue":"6","key":"10.1053\/j.ajkd.2011.12.032_bib59","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.jhep.2011.03.012","article-title":"Diagnosis, treatment and survival of patients with hepatorenal syndrome","volume":"55","author":"Salerno","year":"2011","journal-title":"J Hepatol"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.032_bib60","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/hep.21443","article-title":"Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features","volume":"45","author":"Fasolato","year":"2007","journal-title":"Hepatology"},{"issue":"4, pt 1","key":"10.1053\/j.ajkd.2011.12.032_bib61","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1053\/jhep.2001.27830","article-title":"Renal failure after gastrointestinal bleeding in cirrhosis: incidence, characteristics, predictive factors and prognosis","volume":"34","author":"C\u00e1rdenas","year":"2001","journal-title":"Hepatology"},{"issue":"6","key":"10.1053\/j.ajkd.2011.12.032_bib62","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/0016-5085(88)90691-9","article-title":"Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis","volume":"94","author":"Gin\u00e8s","year":"1988","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1053\/j.ajkd.2011.12.032_bib63","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2010.05.004","article-title":"EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis","volume":"53","author":"Gin\u00e8s","year":"2010","journal-title":"J Hepatol"},{"issue":"6","key":"10.1053\/j.ajkd.2011.12.032_bib64","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/gut.2006.102467","article-title":"Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt","volume":"56","author":"Cazzaniga","year":"2007","journal-title":"Gut"},{"issue":"3","key":"10.1053\/j.ajkd.2011.12.032_bib65","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1055\/s-2007-1007201","article-title":"Hepatorenal syndrome","volume":"17","author":"Bataller","year":"1997","journal-title":"Semin Liver Dis"},{"issue":"9398","key":"10.1053\/j.ajkd.2011.12.032_bib66","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(03)14903-3","article-title":"Hepatorenal syndrome","volume":"362","author":"Gin\u00e8s","year":"2003","journal-title":"Lancet"},{"key":"10.1053\/j.ajkd.2011.12.032_bib67","series-title":"Ascites and Renal Dysfunction in Liver Disease","first-page":"372","article-title":"Drug-induced renal failure in cirrhosis","author":"Salerno","year":"2005"},{"issue":"7","key":"10.1053\/j.ajkd.2011.12.032_bib68","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1478-3231.2006.01302.x","article-title":"Prognostic factors for patients with cirrhosis and kidney dysfunction in the era of MELD: results of a prospective study","volume":"26","author":"Schepke","year":"2006","journal-title":"Liver Int"},{"issue":"2","key":"10.1053\/j.ajkd.2011.12.032_bib69","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/jhep.2002.34613","article-title":"Hepatitis C infection and the patient with end-stage renal disease","volume":"36","author":"Fabrizi","year":"2002","journal-title":"Hepatology"},{"issue":"4","key":"10.1053\/j.ajkd.2011.12.032_bib70","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jhep.2009.11.025","article-title":"The evaluation of renal function and disease in patients with cirrhosis","volume":"52","author":"Francoz","year":"2010","journal-title":"J Hepatol"},{"issue":"12","key":"10.1053\/j.ajkd.2011.12.032_bib71","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.2215\/CJN.05050610","article-title":"Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis","volume":"5","author":"Targher","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2011.12.032_bib72","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1478-3231.2009.02182.x","article-title":"The spectrum of renal lesions in patients with cirrhosis: a clinicopathological study","volume":"30","author":"Trawal\u00e9","year":"2010","journal-title":"Liver Int"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.032_bib73","doi-asserted-by":"crossref","first-page":"R4","DOI":"10.1186\/cc6765","article-title":"Effects of plasma expansion with albumin and pracentesis on hemodynamics and kidney function in critically ill cirrhotic patients with tense ascites and hepatorenal syndrome: a prospective uncontrolled trial","volume":"12","author":"Umgelter","year":"2008","journal-title":"Crit Care"},{"key":"10.1053\/j.ajkd.2011.12.032_bib74","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1478-3231.2010.02272.x","article-title":"Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis","volume":"30","author":"Salerno","year":"2010","journal-title":"Liver Int"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.032_bib75","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-8278(00)80158-0","article-title":"Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome","volume":"33","author":"Uriz","year":"2000","journal-title":"J Hepatol"},{"issue":"4","key":"10.1053\/j.ajkd.2011.12.032_bib76","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1053\/gast.2002.32364","article-title":"Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study","volume":"122","author":"Moreau","year":"2002","journal-title":"Gastroenterology"},{"issue":"4, pt 1","key":"10.1053\/j.ajkd.2011.12.032_bib77","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/jhep.2002.35819","article-title":"Terlipressin therapy with and without albumin for patients with hepatorenal syndrome","volume":"36","author":"Ortega","year":"2002","journal-title":"Hepatology"},{"issue":"2","key":"10.1053\/j.ajkd.2011.12.032_bib78","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1046\/j.1440-1746.2003.02934.x","article-title":"Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial","volume":"18","author":"Solanki","year":"2003","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"10.1053\/j.ajkd.2011.12.032_bib79","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s10620-007-9919-9","article-title":"Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome","volume":"53","author":"Neri","year":"2008","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1053\/j.ajkd.2011.12.032_bib80","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1053\/j.gastro.2008.02.014","article-title":"A prospective, randomized, double blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome (HRS)","volume":"134","author":"Sanyal","year":"2008","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1053\/j.ajkd.2011.12.032_bib81","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","article-title":"Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study","volume":"134","author":"Martin-Llahi","year":"2008","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1053\/j.ajkd.2011.12.032_bib82","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/hep.23286","article-title":"Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome","volume":"51","author":"Gluud","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.032_bib83","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hep.23283","article-title":"Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome","volume":"51","author":"Nazar","year":"2010","journal-title":"Hepatology"},{"issue":"2","key":"10.1053\/j.ajkd.2011.12.032_bib84","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2010.11.020","article-title":"Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics","volume":"55","author":"Boyer","year":"2011","journal-title":"J Hepatol"},{"issue":"6","key":"10.1053\/j.ajkd.2011.12.032_bib85","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1053\/j.ajkd.2011.07.017","article-title":"Therapeutic response to vasoconstrictors in hepatorenal syndrome parallels increase in mean arterial pressure: a pooled analysis of clinical trials","volume":"58","author":"Velez","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2011.12.032_bib86","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jhep.2011.02.006","article-title":"Pharmacological management of hepatorenal syndrome","volume":"55","author":"Gin\u00e8s","year":"2011","journal-title":"J Hepatol"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.032_bib87","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/hep.20262","article-title":"Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome","volume":"40","author":"Wong","year":"2004","journal-title":"Hepatology"},{"issue":"6","key":"10.1053\/j.ajkd.2011.12.032_bib88","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.510290629","article-title":"Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide","volume":"29","author":"Angeli","year":"1999","journal-title":"Hepatology"},{"issue":"2","key":"10.1053\/j.ajkd.2011.12.032_bib89","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/jhep.2002.34343","article-title":"Effects of noradrenaline and albumin in patients with type 1 hepatorenal syndrome: a pilot study","volume":"36","author":"Duvoux","year":"2002","journal-title":"Hepatology"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.032_bib90","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1523-1755.2005.00408.x","article-title":"Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy","volume":"68","author":"Wong","year":"2005","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ajkd.2011.12.032_bib91","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/lt.500060326","article-title":"Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial","volume":"6","author":"Mitzner","year":"2000","journal-title":"Liver Transpl"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2011.12.032_bib92","doi-asserted-by":"crossref","first-page":"S459","DOI":"10.1016\/S0168-8278(10)61185-3","article-title":"Extracorporeal liver support with the molecular adsorbent recirculating system (MARS) in patients with acute-on-chronic liver failure (AOCLF)","volume":"52","author":"Ba\u00f1ares","year":"2010","journal-title":"J Hepatol"},{"key":"10.1053\/j.ajkd.2011.12.032_bib93","doi-asserted-by":"crossref","unstructured":"Kribben A, Gerken G, Haag S, et al; HELIOS Study Group. Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure [published online ahead of print January 13, 2012]. Gastroenterology. doi:10.1053\/j.gastro.2011.12.056.","DOI":"10.1053\/j.gastro.2011.12.056"},{"issue":"3","key":"10.1053\/j.ajkd.2011.12.032_bib94","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/gut.2008.174615","article-title":"Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment","volume":"59","author":"Wong","year":"2010","journal-title":"Gut"},{"issue":"2","key":"10.1053\/j.ajkd.2011.12.032_bib95","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/hep.510280219","article-title":"Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems","volume":"28","author":"Guevara","year":"1998","journal-title":"Hepatology"},{"issue":"2","key":"10.1053\/j.ajkd.2011.12.032_bib96","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/gut.47.2.288","article-title":"Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study","volume":"47","author":"Brensing","year":"2000","journal-title":"Gut"},{"issue":"11","key":"10.1053\/j.ajkd.2011.12.032_bib97","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1111\/j.1600-6143.2008.02416.x","article-title":"Proceedings of Consensus Conference on simultaneous liver kidney transplantation (SLK)","volume":"8","author":"Eason","year":"2008","journal-title":"Am J Transplant"},{"issue":"11 suppl 2","key":"10.1053\/j.ajkd.2011.12.032_bib98","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1002\/lt.21877","article-title":"Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation","volume":"15","author":"Charlton","year":"2009","journal-title":"Liver Transpl"},{"issue":"10","key":"10.1053\/j.ajkd.2011.12.032_bib99","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/TP.0b013e31821690bf","article-title":"Liver transplantation outcomes for patients with hepatorenal syndrome treated with pretransplant vasoconstrictors and albumin","volume":"91","author":"Rice","year":"2011","journal-title":"Transplantation"},{"issue":"11","key":"10.1053\/j.ajkd.2011.12.032_bib100","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/lt.22395","article-title":"Impact of liver transplantation for the survival of patients treated for hepatorenal syndrome type-1","volume":"17","author":"Boyer","year":"2011","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.032_bib101","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/j.jhep.2003.09.019","article-title":"Effects of treatment of hepatorenal syndrome before transplantation on post-transplantation outcome","volume":"40","author":"Restuccia","year":"2004","journal-title":"J Hepatol"},{"issue":"11","key":"10.1053\/j.ajkd.2011.12.032_bib102","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/lt.22433","article-title":"Pharmacological therapy, hepatorenal syndrome, and liver transplantation","volume":"17","author":"Gin\u00e8s","year":"2011","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1053\/j.ajkd.2011.12.032_bib103","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1053\/gast.2002.37073","article-title":"Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis","volume":"123","author":"Gin\u00e8s","year":"2002","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1053\/j.ajkd.2011.12.032_bib104","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short term survival in severe acute alcoholic hepatitis: a double blind placebo controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1053\/j.ajkd.2011.12.032_bib105","first-page":"391A","article-title":"Addition of pentoxifylline to prednisolone for severe alcoholic hepatitis does not improve 6 month survival: results of the Corpentox trial [abstract]","volume":"54","author":"Mathurin","year":"2011","journal-title":"Hepatology"},{"issue":"3","key":"10.1053\/j.ajkd.2011.12.032_bib106","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jhep.2011.08.020","article-title":"Tolvaptan, an oral vasopressin antagonist in the treatment of hyponatremia in cirrhosis","volume":"56","author":"C\u00e1rdenas","year":"2012","journal-title":"J Hepatol"},{"issue":"6","key":"10.1053\/j.ajkd.2011.12.032_bib107","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1002\/hep.22853","article-title":"Management of adult patients with ascites due to cirrhosis: an update","volume":"49","author":"Runyon","year":"2009","journal-title":"Hepatology"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638612004593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638612004593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:58:43Z","timestamp":1759456723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638612004593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":107,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0272638612004593"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2011.12.032","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatorenal Syndrome: A Severe, but Treatable, Cause of Kidney Failure in Cirrhosis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2011.12.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}